Cargando…
PBX3 in Cancer
PBX3 is a homeodomain-containing transcription factor of the pre-B cell leukemia (PBX) family, members of which have extensive roles in early development and some adult processes. A number of features distinguish PBX3 from other PBX proteins, including the ability to form specific and stable interac...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072649/ https://www.ncbi.nlm.nih.gov/pubmed/32069812 http://dx.doi.org/10.3390/cancers12020431 |
_version_ | 1783506455703322624 |
---|---|
author | Morgan, Richard Pandha, Hardev S |
author_facet | Morgan, Richard Pandha, Hardev S |
author_sort | Morgan, Richard |
collection | PubMed |
description | PBX3 is a homeodomain-containing transcription factor of the pre-B cell leukemia (PBX) family, members of which have extensive roles in early development and some adult processes. A number of features distinguish PBX3 from other PBX proteins, including the ability to form specific and stable interactions with DNA in the absence of cofactors. PBX3 has frequently been reported as having a role in the development and maintenance of a malignant phenotype, and high levels of PBX3 tumor expression have been linked to shorter overall survival in cancer. In this review we consider the similarities and differences in the function of PBX3 in different cancer types and draw together the core signaling pathways involved to help provide a better insight into its potential as a therapeutic target. |
format | Online Article Text |
id | pubmed-7072649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70726492020-03-19 PBX3 in Cancer Morgan, Richard Pandha, Hardev S Cancers (Basel) Review PBX3 is a homeodomain-containing transcription factor of the pre-B cell leukemia (PBX) family, members of which have extensive roles in early development and some adult processes. A number of features distinguish PBX3 from other PBX proteins, including the ability to form specific and stable interactions with DNA in the absence of cofactors. PBX3 has frequently been reported as having a role in the development and maintenance of a malignant phenotype, and high levels of PBX3 tumor expression have been linked to shorter overall survival in cancer. In this review we consider the similarities and differences in the function of PBX3 in different cancer types and draw together the core signaling pathways involved to help provide a better insight into its potential as a therapeutic target. MDPI 2020-02-13 /pmc/articles/PMC7072649/ /pubmed/32069812 http://dx.doi.org/10.3390/cancers12020431 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Morgan, Richard Pandha, Hardev S PBX3 in Cancer |
title | PBX3 in Cancer |
title_full | PBX3 in Cancer |
title_fullStr | PBX3 in Cancer |
title_full_unstemmed | PBX3 in Cancer |
title_short | PBX3 in Cancer |
title_sort | pbx3 in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072649/ https://www.ncbi.nlm.nih.gov/pubmed/32069812 http://dx.doi.org/10.3390/cancers12020431 |
work_keys_str_mv | AT morganrichard pbx3incancer AT pandhahardevs pbx3incancer |